|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.3 USD | +0.30% |
|
-0.56% | -3.43% |
| Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
| Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
Shares of Abbott Laboratories slipped after the medical-device maker forecast second-quarter earnings short of some investors' expectations. "Health Care Down After Abbott Earnings -- Health Care Roundup" at 5:35 p.m. ET April 17 incorrectly said earnings were short of expectations.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
04-18-24 1306ET
| 1st Jan change | Capi. | |
|---|---|---|
| -3.43% | 184B | |
| -1.81% | 107B | |
| -4.15% | 67.78B | |
| +1.43% | 50.66B | |
| +11.60% | 47.64B | |
| +4.60% | 41.12B | |
| +3.03% | 26.3B | |
| +3.21% | 26.04B | |
| +15.06% | 25.4B | |
| -1.76% | 24.71B |
ABBOTT LABORATORIES 
